MAP2K7 and cancer: Of note, however, additional irradiation was found to confer pronounced additional reduction in clonogenicity in both of the KRAS mutant cancer cell lines tested, suggesting potential therapeutic efficacy of KRAS inhibition by BI-3406 in combination with MEK inhibition and irradiation (Figure 3a–d).